๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Pacific Oncololgy & Hematology
Start Date
2009-06
Trial ID
NCT00920855
Treatments Being Tested
The purpose of this study is to determine if an extended maintenance therap...
Status
Active Not Recruiting
Location
StiL Head Office; Justus-Liebig-University
Start Date
2009-04-01
Trial ID
NCT00877214
Treatments Being Tested
Many cancer patients are prescribed drugs to which their cancer is already ...
Status
Completed
Location
Seattle Cancer Care Alliance
Start Date
2012-11
Trial ID
NCT01831505
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
This is a study to evaluate the efficacy and safety of Bendamustine Hydroch...
Status
Completed
Location
Fujian Cancer Hospital
Start Date
2012-05
Trial ID
NCT04569838
Treatments Being Tested
This is a single-arm, open, single-center clinical study. Patients with lym...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-01
Trial ID
NCT06757478
Compare the efficacy and safety of Orelabrutinib plus bendamustine+ rituxim...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-05-29
Trial ID
NCT06363994
Treatments Being Tested
The goal of this clinical research study is to learn if adding Zevalin (ibr...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-01
Trial ID
NCT01490723
The purpose of this study was to evaluate the safety and efficacy of ofatum...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-08-26
Trial ID
NCT01077518
The purpose of this study is to determine the recommended dose for the comb...
Status
Withdrawn
Location
Local Institution
Start Date
2009-05
Trial ID
NCT00872976